Chronic Obstructive Pulmonary Disease — Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease
Citation(s)
A Phase II Safety Study of TAK-375 in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease